These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17289747)

  • 1. Variability in response to clopidogrel: where is the threshold for 'low response'?
    Dániel A; Pintér T; Horváth IG; Komócsi A
    Eur Heart J; 2007 Feb; 28(4):515-6; author reply 516. PubMed ID: 17289747
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term clopidogrel therapy in the drug-eluting stent era: beyond CREDO and PCI-CURE.
    Koh TW
    Eur Heart J; 2004 Aug; 25(15):1364; author reply 1364-5. PubMed ID: 15288165
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel and percutaneous coronary intervention.
    Cannon C
    Lancet; 2002 Jan; 359(9301):169. PubMed ID: 11809292
    [No Abstract]   [Full Text] [Related]  

  • 4. Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.
    Heptinstall S
    J Thromb Haemost; 2006 Mar; 4(3):539-41. PubMed ID: 16405519
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction of statins with clopidogrel].
    Von Scheidt W
    Internist (Berl); 2004 Mar; 45(3):363-5. PubMed ID: 14997315
    [No Abstract]   [Full Text] [Related]  

  • 6. For how long should treatment with clopidogrel be continued after coronary stent implantation?
    Rozenman Y
    J Am Coll Cardiol; 2004 Apr; 43(7):1331; author reply 1331-2. PubMed ID: 15063450
    [No Abstract]   [Full Text] [Related]  

  • 7. Duration of clopidogrel therapy with drug-eluting stents.
    Okura H
    N Engl J Med; 2010 Jul; 363(5):488; author reply 490. PubMed ID: 20666628
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of clopidogrel therapy with drug-eluting stents.
    Memtsoudis SG; Sharrock NE
    N Engl J Med; 2010 Jul; 363(5):488-9; author reply 490. PubMed ID: 20830828
    [No Abstract]   [Full Text] [Related]  

  • 9. Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
    Stadius ML
    J Am Coll Cardiol; 2004 Jul; 44(1):25-7. PubMed ID: 15234400
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High postclopidogrel platelet reactivity in non-ST-elevation acute coronary syndrome treated with stenting: a clue for adverse prognosis?
    Galvani M
    J Thromb Haemost; 2006 Mar; 4(3):536-8. PubMed ID: 16460436
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel resistance: a new chapter in a fast-moving story.
    Wiviott SD; Antman EM
    Circulation; 2004 Jun; 109(25):3064-7. PubMed ID: 15226220
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel under scrutiny.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):925-6. PubMed ID: 19016464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
    Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E
    Ital Heart J Suppl; 2003 Sep; 4(9):766-70. PubMed ID: 14635395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
    O'Donoghue M; Wiviott SD
    Circulation; 2006 Nov; 114(22):e600-6. PubMed ID: 17130347
    [No Abstract]   [Full Text] [Related]  

  • 17. Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
    Saw J; Moliterno DJ
    Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When guidelines collide..
    Spencer FA; Becker RC
    Am Heart J; 2004 Mar; 147(3):395-7. PubMed ID: 14999185
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy for ischemic heart disease.
    Lange RA; Hillis LD
    N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.